TE_27174

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MER52A
TE superfamily ERV1
TE class LTR
Gene CPB2
Class Chimeric
Coding Non-coding
Tumor-specific score 234.44
Counts of samples TCGA_tumor:207; TCGA_normal:0; GTEx:0
TSS chr13(-):46086519



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_27174.1 CPB2 Chimeric Non-coding Non-coding chr13(-):46053778,46053798,46055762,46055849,46058179,46058381,46064648,46064741,46067307,46067417,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084343,46085258,46086520
teRNA_27174.2 CPB2 Chimeric Non-coding Non-coding chr13(-):46053778,46053798,46055762,46055849,46058179,46058381,46064648,46064741,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084343,46085258,46086520
teRNA_27174.3 CPB2 Chimeric Non-coding Non-coding chr13(-):46053778,46053798,46055762,46055849,46058179,46058381,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084343,46085258,46086520
teRNA_27174.4 CPB2 Chimeric Non-coding Non-coding chr13(-):46073482,46073502,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084343,46085258,46086520
teRNA_27174.5 CPB2 Chimeric Non-coding Non-coding chr13(-):46053778,46053798,46055762,46055849,46058179,46058381,46064648,46064741,46067307,46067417,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084328,46085258,46086520
teRNA_27174.6 CPB2 Chimeric Non-coding Non-coding chr13(-):46053778,46053798,46055762,46055849,46058179,46058381,46064648,46064741,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084328,46085258,46086520
teRNA_27174.7 CPB2 Chimeric Non-coding Non-coding chr13(-):46053778,46053798,46055762,46055849,46058179,46058381,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084328,46085258,46086520
teRNA_27174.8 CPB2 Chimeric Non-coding Non-coding chr13(-):46073482,46073502,46073873,46073977,46078800,46078901,46082441,46082549,46084219,46084328,46085258,46086520


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).